Feasel Michael G, Moran Theodore S, Cheng Boyle C, Averick Saadyah
Defense Advanced Research Projects Agency (DARPA), Biological Technologies Office (BTO), Arlington, VA, United States.
U.S. Army DEVCOM Chemical and Biological Center, Aberdeen, MD, United States.
Front Psychiatry. 2024 Feb 20;15:1359851. doi: 10.3389/fpsyt.2024.1359851. eCollection 2024.
The rapid rise in deaths since 2012 due to opioid poisoning is correlated with the proliferation of potent synthetic opioid agonists such as fentanyl, acrylfentanyl, and carfentanil. The efficacy of frontline antidotes such as naloxone in reversing such poisoning events has been questioned, and the possibility of naloxone-resistant synthetic opioids has been raised. In this manuscript, we applied techniques to establish the median effective inhibitory concentrations for fentanyl, acrylfentanyl, and carfentanil and subsequently evaluate naloxone's ability to reverse agonist-receptor interactions.
自2012年以来,因阿片类药物中毒导致的死亡人数迅速上升,这与强效合成阿片类激动剂(如芬太尼、丙烯酰芬太尼和卡芬太尼)的扩散有关。纳洛酮等一线解毒剂在逆转此类中毒事件中的疗效受到质疑,耐纳洛酮合成阿片类药物的可能性也已被提出。在本论文中,我们应用技术确定了芬太尼、丙烯酰芬太尼和卡芬太尼的半数有效抑制浓度,随后评估了纳洛酮逆转激动剂-受体相互作用的能力。